...
首页> 外文期刊>International Journal of Pharmaceutics >Application of a mixture DOE for the prediction of formulation critical temperatures during lyophilisation process optimisation
【24h】

Application of a mixture DOE for the prediction of formulation critical temperatures during lyophilisation process optimisation

机译:混合物DOE在冻干过程优化期间对制剂临界温度预测的应用

获取原文
获取原文并翻译 | 示例
           

摘要

During lyophilisation cycle design, primary drying parameters (chamber pressure and shelf temperature) are adjusted to maximize the sublimation rate and prevent cake collapse, by maintaining the product continuously below its critical temperatures. The objective of this study was to employ mixture design of experiments to generate empirical models capable of predicting glass transition of the maximally freeze concentrated solution (Tg') and collapse temperature (Tc) of amorphous protein (BSA and IgG1) formulations. Additionally, the models developed aid the design of high concentration protein formulations with maximised critical temperatures to obtain shorter and more cost-effective lyophilisation cycles. Formulations contain sucrose as cryo/lyo-protectant and arginine/arginine-HCl as multifunctional excipient (e.g. solubility enhancer, viscosity and aggregation suppressor). The impact of formulation components at varied ratios on critical temperatures was evaluated; the amorphous excipients decrease critical temperatures, on the contrary, the protein increases critical temperatures. The robustness of the empirical models generated with BSA formulations was verified with BSA and IgG1 formulations. The models showed greater accuracy in predicting Tg' than the Fox-Flory equation. For the first time, empirical models are reported to predict both critical temperatures. Finally, unconventional collapse events observed for formulations with and without arginine/arginine-HCl at different protein concentrations are also discussed.
机译:在冷冻干燥循环设计期间,调节​​初级干燥参数(室压力和搁板温度)以通过在其临界温度下保持产品通过将产品保持在其临界温度下最大化升华速率并防止滤饼塌陷。本研究的目的是利用模拟实验设计,以产生能够预测无定形蛋白(BSA和IgG1)制剂的最大冷冻浓缩溶液(Tg')和塌陷温度(Tc)的玻璃化转变的实证模型。此外,该模型开发了辅助高浓度蛋白质制剂的设计,具有最大化的临界温度,以获得更短,更具成本效益的冻干循环。制剂含有蔗糖作为冷冻/润载物保护剂和精氨酸/精氨酸-HCl,作为多功能赋形剂(例如溶解度增强剂,粘度和聚集抑制剂)。评估了制剂组分在各种比率对临界温度的影响;无定形赋形剂减少临界温度,相反,蛋白质增加了临界温度。用BSA配方产生的经验模型的稳健性用BSA和IgG1制剂验证。该模型在预测TG'比狐狸浮血方程方面表现出更高的准确性。首次,据报道,经验模型预测临界温度。最后,还讨论了在不同蛋白质浓度下观察到具有和不具有精氨酸/精氨酸-HCl的制剂的非常规崩溃事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号